🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

California hospitals overrun even as vaccine is rolled out

Published 12/18/2020, 08:03 PM
Updated 12/18/2020, 09:51 PM
© Reuters. U.S. Vice President Mike Pence receives the COVID-19 vaccine at the White House in Washington
PFE
-
BX
-
FRO
-
MRNA
-

By Sharon Bernstein and Jeff Mason

SACRAMENTO, Calif. (Reuters) - Even as high profile figures like U.S. Vice President Mike Pence rolled up their sleeves for COVID-19 vaccinations, patients already ill with the disease crowded emergency rooms and overran intensive care units in California, now a worldwide epicenter.

Another 41,000 people tested positive in the most populous U.S. state on Thursday, and 300 died, state public health officials said. In a state with 40 million residents, only about 1,200 intensive care beds remained available by Friday - just 2.1% of the total, the California Department of Public Health said.

"We anticipated a surge, but I'm not sure if anyone imagined it would be as bad as it has been," said Adam Blackstone (NYSE:BX), a spokesman for the Hospital Association of Southern California.

California's struggle opens a window onto the coronavirus' deadly rampage across the United States, even as vaccines provide hope that the pandemic may soon end.

The United States leads the world in new coronavirus cases, reporting a record 239,903 new cases on Thursday, Reuters data shows. The U.S. death toll surpassed 311,000, and U.S. hospitalizations have set records on each of the past 20 days, approaching 114,000 on Thursday, according to a Reuters tally.

In California, the total number of cases rose to nearly 1.8 million, with more than 22,000 deaths.

One vaccine, made by the pharmaceutical giant Pfizer (NYSE:PFE), has already been distributed to U.S. states and inoculations have begun. Rollout of a second, by Moderna (NASDAQ:MRNA) Inc is expected as early as this weekend. The Moderna vaccine was approved for use in the pandemic by the U.S. Food and Drug Administration on Friday.

But it will be months before the impact of the new vaccines will slow the progress of the pandemic. New cases are still rising in more than a dozen U.S. states.

In California, hospitals are strained, with some serving the sick in tents set up outside in chilly weather, and people awaiting care in hallways. Intensive care units were completely full in densely populated Southern California, which includes Los Angeles, as well as in agricultural hub San Joaquin Valley, the state said.

Nearly all of the state is under emergency stay-at-home orders, after the San Francisco Bay Area ran low on intensive care beds on Friday and was added to a shutdown list that already included Southern California, the San Joaquin Valley and the Sacramento region.

"We expect to have more dead bodies than we have spaces for them," Los Angeles Mayor Eric Garcetti told a briefing on Thursday.

California's woes will likely worsen as patients who contracted the disease over Thanksgiving are joined by those exposed after gathering with friends and family for Christmas and Hanukkah, Blackstone said.

Pence received his COVID-19 vaccine live on television on Friday, seeking to shore up public support for vaccinations as U.S. regulators were on the cusp of approving a second vaccine for emergency use.

After U.S. deaths from the coronavirus topped 3,000 for a third straight day, Pence called the vaccinations a sign of hope, with 20 million doses expected to be distributed nationwide before the end of December and hundreds of millions more going out in the first half of 2021.

"I also believe that history will record that this week was the beginning of the end of the coronavirus pandemic, but with cases rising across the country, hospitalizations rising across the country, we have a ways to go," said Pence, leader of the White House coronavirus task force.

Beyond the logistical challenge of the most ambitious vaccination campaign in decades, health officials must convince a skeptical public vaccines are safe and effective. A recent Reuters/Ipsos poll found only 61% of Americans were open to getting vaccinated.

Pence and other officials being vaccinated publicly "is symbolic to tell the rest of the country the time is now to step to the plate, and when your time comes, to get vaccinated," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease.

Frontline (NYSE:FRO) healthcare workers, first responders and nursing home residents have been given priority, but a parade of high-profile inoculations could soon follow. Fauci, who still sees patients, has said he might receive the vaccine within days.

Former Presidents Bill Clinton, George W. Bush and Barack Obama have volunteered for public inoculations, and President-elect Joe Biden, who is due to take office on Jan. 20, will get his next week, his aides said.

While departing President Donald Trump has yet to embrace messages about social distancing and mask-wearing, he has encouraged people to get vaccinated and championed his administration's Operation Warp Speed program to promote development and distribution of vaccines.

© Reuters. U.S. Vice President Mike Pence receives the COVID-19 vaccine at the White House in Washington

But Trump, who survived a bout with COVID-19 a few weeks before losing the Nov. 3 election to Biden, has yet to announce his plans for getting a shot.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.